mRNA-LNPs樣品測試實例展示

知識鏈接

[1] Chen, X., Gao, Y., Li, J., Guo, H., Wang, Z., & Gao, S. (2023). mRNA脂質納米粒載藥系統(tǒng)的構建及體外評價 [Construction and in vitro evaluation of mRNA lipid nanoparticle drug delivery system]. 藥學實踐與服務 Journal of Pharmaceutical Practice and Service, 41(5), 291-295.

[2] Fahr, S., Pe?a-Benavides, S.A., Thiel, L., Sengoba, C., Karacasulu, K., Ihling, N., Sosa-Hernández, J.E., Gilleskie, G., Woodley, J.M., Parra-Saldívar, R., Mansouri, S.S., & Roh, K. (2022). Mobile On Demand COVID-19 Vaccine Production Units for Developing Countries. Industrial & Engineering Chemistry Research.

[3] Kamiya, M., Matsumoto, M., Yamashita, K., Izumi, T., Kawaguchi, M., Mizukami, S., Tsurumaru, M., Mukai, H., & Kawakami, S. (2022). Stability Study of mRNA-Lipid Nanoparticles Exposed to Various Conditions Based on the Evaluation between Physicochemical Properties and Their Relation with Protein Expression Ability. Pharmaceutics, 14(11), 2357. 

[4] Hashiba, K., Taguchi, M., Sakamoto, S., Otsu, A., Maeda, Y., Ebe, H., Okazaki, A., Harashima, H., & Sato, Y. (2024). Overcoming thermostability challenges in mRNA-lipid nanoparticle systems with piperidine-based ionizable lipids. Communications biology, 7(1), 556. 

往期推薦